Shortness of Breath (Dyspnea): As a well-established mucolytic agent, NAC breaks down the disulfide bonds in thick mucus, helping to clear airway secretions and improve respiratory function, while also reducing microvascular inflammation in the lungs
Common protocols reference BPC 157 at 200500 mcg daily and TB 500 with a 46 mg/week loading phase followed by 24 mg/week maintenance, typically via subcutaneous injection
A 2024 study in ex vivo follicles showed GHK-Cu upregulated -catenin by 40%, rivaling valproic acid (Lee et al., 2024)
Often explored for supporting energy production, insulin sensitivity, cellular resilience, and long-term wellness pathways especially in routines focused on performance and metabolic heal Start Low
Inhaled forms may trigger asthma symptoms in patients with asthma